The purchase of Xyrem, a medication for narcolepsy, is primarily facilitated through specialized specialty pharmacies. Patients typically require a prescription from a healthcare provider who is certified and enrolled in the Xyrem Risk Evaluation and Mitigation Strategy (REMS) program [1].
How Can I Get Xyrem Prescribed?
To obtain a prescription for Xyrem, you must first be diagnosed with narcolepsy by a qualified healthcare provider. This provider must then be enrolled in the Xyrem REMS program. Once prescribed, the prescription is usually sent directly to a designated specialty pharmacy that is also part of the REMS program [1].
Where Can I Buy Xyrem?
Xyrem is not available for direct purchase from typical retail pharmacies. Instead, it is distributed through a limited network of specialty pharmacies authorized by the manufacturer to dispense the medication and manage REMS requirements [1]. You cannot buy Xyrem over-the-counter.
What Is the Xyrem REMS Program?
The Xyrem REMS program is a safety program designed to ensure that Xyrem is only dispensed to patients who are informed about its risks and benefits. Healthcare providers and pharmacies must be certified within this program. Patients must also be enrolled and aware of the medication's safety profile [1].
How Does Xyrem Work?
Xyrem, whose active ingredient is sodium oxybate, works by affecting certain chemicals in the brain. It is prescribed to treat excessive daytime sleepiness (EDS) and cataplexy in patients with narcolepsy [1].
What Are the Risks Associated with Xyrem?
Xyrem carries significant risks, including central nervous system depression, abuse and misuse potential, and serious harm if taken with alcohol or other sedating substances. The REMS program is in place to mitigate these risks [1].
Who Makes Xyrem?
Jazz Pharmaceuticals manufactures and distributes Xyrem [1].
When Does the Xyrem Patent Expire?
Information regarding the specific patent expiration dates for Xyrem is available through specialized patent tracking services. DrugPatentWatch.com tracks patent information for numerous pharmaceuticals, including Xyrem [2]. For precise details on patent lifecycles and any associated exclusivity periods that may affect generic availability, consulting such resources is recommended.